How does hfm start

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: HFM disease typically starts with a sudden onset of fever, often reaching 101-104°F (38.3-40°C), followed by the development of painful mouth sores and a skin rash within 1-2 days. The initial symptoms usually appear 3-6 days after exposure to the virus, with the fever lasting 2-3 days before subsiding. The characteristic rash begins as small red spots that develop into painful blisters on hands, feet, and sometimes buttocks, with mouth sores appearing as small ulcers on the tongue, gums, and inside cheeks.

Key Facts

Overview

Hand, foot, and mouth disease (HFMD) is a common viral illness primarily affecting infants and young children under 5 years old, though it can occasionally occur in adults. First described in 1957, HFMD is caused by enteroviruses, most commonly Coxsackievirus A16 (accounting for approximately 70-80% of cases) and Enterovirus 71 (EV71), which can cause more severe complications. The disease is highly contagious, spreading through direct contact with infected persons, respiratory droplets from coughs or sneezes, contact with contaminated surfaces, or fecal-oral transmission. Global incidence varies by region, with tropical and subtropical areas experiencing year-round transmission, while temperate regions see seasonal peaks in summer and fall. According to the World Health Organization, large outbreaks have occurred in the Asia-Pacific region, with China reporting over 1.7 million cases in 2010 alone. The disease is generally mild and self-limiting, with most cases resolving within 7-10 days without specific treatment.

How It Works

HFMD begins when enteroviruses enter the body through the mouth or respiratory tract, typically via contaminated hands, surfaces, or respiratory droplets. The virus initially replicates in the lymphoid tissues of the throat and intestines during an incubation period of 3-6 days. Viral particles then enter the bloodstream (viremia), spreading throughout the body and targeting specific tissues including skin and mucous membranes. This systemic spread triggers the characteristic symptoms: fever results from the body's immune response to the virus, while the skin rash and mouth sores develop as the virus infects epithelial cells in these areas. The rash typically appears first on palms and soles as small red macules that evolve into grayish vesicles 2-5mm in diameter, often with a characteristic oval shape and surrounded by red halos. Simultaneously, painful oral ulcers develop on the tongue, gums, and buccal mucosa, making eating and drinking difficult. The virus is shed in stool for several weeks after symptoms resolve, contributing to ongoing transmission. Diagnosis is primarily clinical based on characteristic symptoms, though laboratory confirmation through PCR testing of throat swabs or stool samples is available for severe cases or outbreak investigations.

Why It Matters

HFMD matters significantly due to its high transmissibility and impact on childcare settings, schools, and families. Outbreaks frequently lead to school closures and parental work absences, with economic impacts estimated at millions annually in affected regions. While most cases are mild, severe complications can occur, particularly with EV71 strains, including viral meningitis (affecting approximately 1-2% of cases), encephalitis, acute flaccid paralysis, and neurogenic pulmonary edema with mortality rates up to 10% in severe neurological cases. The disease disproportionately affects young children in daycare settings where close contact facilitates rapid spread, with attack rates reaching 50-80% during outbreaks. Public health responses include isolation of infected individuals, enhanced hygiene measures, and in some regions, vaccination programs against EV71. Research continues into improved diagnostics and treatments, with recent vaccine developments in China showing 90-95% efficacy against severe EV71-associated HFMD. Understanding HFMD's transmission patterns helps implement effective prevention strategies in vulnerable populations.

Sources

  1. Wikipedia - Hand, Foot, and Mouth DiseaseCC-BY-SA-4.0

Missing an answer?

Suggest a question and we'll generate an answer for it.